Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. Clin Cardiol. 2018 Oct; 41(10):1281-1288.

View in: PubMed

subject areas

Carboxylic Acids
Cardiovascular Diseases
Cholesterol, HDL
Fatty Acids, Omega-3
Global Health
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertriglyceridemia
Incidence
Randomized Controlled Trials as Topic
Risk Factors
Triglycerides

authors with profiles

Michael H. Davidson